LifeSteps Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Buy
+152
New +$7.86K 0.01% 400
2024
Q2
Sell
-152
Closed -$16.2K 283
2024
Q1
$16.2K Buy
+152
New +$15.3K 0.01% 250

Other funds holding MRNA

LifeSteps Financial's MRNA Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Moderna (MRNA) in Q2 2026: 152 shares worth $10.6K. The stake represents 0.01% of the portfolio and ranks #400 among its holdings. This is a return to the name: LifeSteps Financial previously reported a position in MRNA as recently as Q1 2024.

LifeSteps Financial first reported a position in MRNA in Q1 2024 and has held it in 2 quarters since. The position peaked at $16.2K in Q1 2024. 164 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • LifeSteps Financial held 152 shares of Moderna worth $10.6K as of Q2 2026.
  • Moderna was a new LifeSteps Financial position in Q2 2026.
  • Moderna made up 0.01% of LifeSteps Financial's portfolio in Q2 2026, its #400 holding.
  • LifeSteps Financial first reported a position in Moderna in Q1 2024 and has held it in 2 quarters since.
  • LifeSteps Financial's Moderna position peaked at $16.2K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.